Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Pharma
Sanofi expands price cut to $35 monthly for all insulin products
In an expansion of its previous moves to cut the price of insulin in the U.S., Sanofi now will sell all of its insulin products for $35 per month.
Kevin Dunleavy
Sep 26, 2025 1:00pm
Celltrion buy, Rexulti CRL, Glenmark-Hengrui—Fierce Pharma Asia
Sep 26, 2025 10:00am
Eli Lilly's oral SERD Inluriyo crosses FDA finish line
Sep 25, 2025 3:35pm
Moderna crowns new UK facility as other pharmas pile on Britain
Sep 25, 2025 9:55am
England is not attractive place for investment, Lilly CEO says
Sep 24, 2025 10:52am
Lilly reveals plans for $6.5B API production facility in Texas
Sep 23, 2025 1:00pm